PrEPared to choose: the protocol for an implementation study of the delivery of cabotegravir long-acting injectable pre-exposure prophylaxis (PrEP) as an HIV prevention product option within a real world PrEP choice context in cape town
Related Posts
Gu Y, Ibrahim BA, Gebremariam T, Alkhazraji S, Aerts R, Vanbiervliet Y, Lagrou K, Maertens J, Prattes J, Egger M, Dichtl K, Jenks JD, Hoenigl[...]
Lohan S, Tiwari RK, Maslennikov I, Das Gupta K, Singh S, Parang K. Selectivity Modulation of Small Cationic Membrane-Active Cyclic Peptides with Broad-Spectrum Activity against[...]
Basnet D, Golenbock S, Strymish JM, Mull HJ, Lamkin RP, Shin M, Harvey K, Karchmer AW, Branch-Elliman W. Bloodstream Infections Among Veterans With Cardiac Implantable[...]